Optimal ranges: Men under 45 U/L Women under 35 U/L A ratio greater than 2:1 (AST significantly higher than ALT) may indicate alcohol-related liver stress
Treat the change as a new start on tirzepatide rather than a milligram-for-milligram swap
That theory is superficially appealing and, importantly, has never been formally tested
The KFF 2025 Employer Health Benefits Survey provides the most granular picture to date: 43% of firms with 5,000+ workers cover GLP-1s for weight loss (up from 28% in 2024), while 30% of firms with 1,0004,999 workers and 16% of firms with 200999 workers do so ( [6] )
Results on glycemic efficacy of these crucial studies are summarized here for the doses which were selected as the clinical doses
So,with that in place, i have stopped fencing with my GP, and i am trying to get on with my everyday